A Bottom-up Whole-body Physiologically-based Pharmacokinetic Model to Mechanistically Predict Tissue Distribution and the Rate of Subcutaneous Absorption of Therapeutic Proteins

ホーム / A Bottom-up Whole-body Physiologically-based Pharmacokinetic Model to Mechanistically Predict Tissue Distribution and the Rate of Subcutaneous Absorption of Therapeutic Proteins

Back to all Publications

A Bottom-up Whole-body Physiologically-based Pharmacokinetic Model to Mechanistically Predict Tissue Distribution and the Rate of Subcutaneous Absorption of Therapeutic Proteins

2016 年 1 月 1 日

Author(s): Katherine Gill, Iain Gardner, Linzhong Li, Masoud Jamei

Year: 2016 年 1 月 1 日

サターラ、バイオシミュレーションを用いたジェネリック医薬品の生物学的同等性のバーチャル評価をさらに前進させるFDA助成金プログラムに採択

プレスリリース

Essentials of Model-informed Drug Development (MIDD) – Top-down vs. Bottom-up Approaches

ブログ (英語)

British Pharmacology Society:
Pharmacology 2021

イベント

Using Simcyp Simulator to Determine DDI Liability of Guanfacine in Children

事例紹介

Powered by Translations.com GlobalLink OneLink Software

サターラ、バイオシミュレーションを用いたジェネリック医薬品の生物学的同等性のバーチャル評価をさらに前進させるFDA助成金プログラムに採択

Essentials of Model-informed Drug Development (MIDD) – Top-down vs. Bottom-up Approaches

British Pharmacology Society:Pharmacology 2021

Using Simcyp Simulator to Determine DDI Liability of Guanfacine in Children

British Pharmacology Society:
Pharmacology 2021